Rosenroot (Rhodiola rosea): Traditional use, chemical composition, pharmacology and clinical efficacy

Abidov, 2003, Effect of extracts from Rhodiola rosea and Rhodiola crenulata (Crassulaceae) roots on ATP content in mitochondria of skeletal muscles, Bull. Exp. Biol. Med., 136, 585, 10.1023/B:BEBM.0000020211.24779.15

Akgul, 2004, Lotaustralin from Rhodiola rosea roots, Fitoterapia, 75, 612, 10.1016/j.fitote.2004.06.002

Aksenova, 1968, Comparative characteristics of the stimulating and adaptogenic effects of Rhodiola rosea preparations, vol. 2, 3

Aksyonova, R.A., 1968. Pharmacology of Rhodioloside. Ph.D. Thesis in Pharmacology, Tomsk State University, Tomsk, USSR. pp. 1–14.

Ali, 2008, Phenylalkanoids and monoterpene analogues from the roots of Rhodiola rosea, Planta Med., 74, 178, 10.1055/s-2008-1034288

Alm, 2004, Ethnobotany of Rhodiola rosea (Crassulaceae) in Norway, SIDA Contrib. Bot., 21, 321

Avula, 2009, RP-HPLC determination of phenylalkanoids and monoterpenoids in Rhodiola rosea and identification by LC-ESI-TOF, Biomed. Chromatogr., 23, 865, 10.1002/bmc.1198

Barnaulov, 1986, A comparative evaluation of the biological activity of compounds isolated from species of Rhodiola, Khim. Pharm. Z., 23, 1107

Basch, 2005

Blomkvist, 2009, Perspective on Roseroot (Rhodiola rosea) studies, Planta Med., 75, 1187, 10.1055/s-0029-1185720

Bocharova, 1995, The effect of a Rhodiola rosea extract on the incidence of recurrences of a superficial bladder cancer (experimental clinical research), Urol. Nefrol. (Mosk.), 2, 46

Boon-Niermeijer, 2000, Phyto-adaptogens protect against environmental stress-induced death of embryos from the freshwater snail Lymnaea stagnalis, Phytomedicine, 7, 389, 10.1016/S0944-7113(00)80060-4

Brekhman, 1968, New substances of plant origin which increase non-specific resistance, Ann. Rev. Pharmacol., 8, 419

Brichenko, 1986, The use of herbal adaptogens together with tricyclic antidepressants in patients with psychogenic depressions, vol. 2, 58

Brown, 2002, Rhodiola rosea: a phyto medicinal overview, Herbal. Gram, 56, 40

Bystritsky, 2008, A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD), J. Altern. Complement. Med., 14, 175, 10.1089/acm.2007.7117

Cai, 2008, Salidroside inhibits H2O2-induced apoptosis in PC12 cells by preventing cytochrome c release and inactivating of caspase cascade, Acta Biochim. Biophys. Sin. (Shanghai), 40, 796, 10.1093/abbs/40.9.796

Cao, 2005, Effect of salidroside on mitochondria injury induced by sodium azide, Yao Xue Xue Bao., 40, 700

Cao, 2006, Effect of salidroside on cell damage induced by glutamate and intracellular free calcium in PC12 cells, J. Asia. Nat. Prod. Res., 8, 159, 10.1080/1028602042000325645

Chang, 2007, Quantitative determination of salidroside in rat plasma by on-line solid-phase extraction integrated with high-performance liquid chromatography/electrospray ionization tandem mass spectrometry, J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 857, 164, 10.1016/j.jchromb.2007.06.029

Chen, 2008, Salidroside attenuates glutamate-induced apoptotic cell death in primary cultured hippocampal neurons of rats, Brain Res., 1238, 189, 10.1016/j.brainres.2008.07.051

Colson, 2005, Cordyceps sinensis- and Rhodiola rosea-based supplementation in male cyclists and its effect on muscle tissue oxygen saturation, J. Strength Cond. Res., 19, 358

Darbinyan, 2007, Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression, Nordic J. Psychiatry, 61, 2343, 10.1080/08039480701643290

Darbinyan, 2000, Rhodiola rosea in stress induced fatigue—a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty, Phytomedicine, 7, 365, 10.1016/S0944-7113(00)80055-0

De Bock, 2004, Acute Rhodiola rosea intake can improve endurance exercise performance, Int. J. Sport Nutr. Exerc. Metab., 14, 298, 10.1123/ijsnem.14.3.298

Diaz-Lanza, 2001, Lignan and phenyl propanoid glycosides from Phillyrea latifolia and their in vitro anti-inflammatory activity, Planta Med., 67, 219, 10.1055/s-2001-12004

Dieamant Gde, 2008, Neuroimmunomodulatory compound for sensitive skin care: in vitro and clinical assessment, J. Cosmet. Dermatol., 7, 112, 10.1111/j.1473-2165.2008.00373.x

Dragland, 2001

Dragland, S., Galambosi, B., 1996. Medisinplanter, Rosenrot, Forskningsparken i Ås., pp. 143–145.

Earnest, 2004, Effects of a commercial herbal-based formula on exercise performance in cyclists, Med. Sci. Sports Exerc., 36, 504, 10.1249/01.MSS.0000125157.49280.AF

EMEA/HMPC/102655/2007. Reflection Paper on the Adaptogenic Concept. European Medicines Agency, London, 8 May 2008

EMEA/HMPC/104613/2005. European Medicines Agency. Committee on Medicinal Products. Available at 〈http://www.emea.europa.eu/pdfs/human/hmpc/10461305en.pdf〉 (Accessed 01/03/2009).

Estonian Ministry of Health Affairs, 1998. Regulation no. 7, Annex 1, 21 January, Government of Estonia, Tallin.

Fintelmann, 2007, Efficacy and tolerability of a Rhodiola rosea extract in adults with physical and cognitive deficiencies, Adv. Ther., 24, 929, 10.1007/BF02849986

Ganzera, 2001, Analysis of the marker compounds of Rhodiola rosea L. (golden root) by reversed phase high performance liquid chromatography, Chem. Pharm. Bull. (Tokyo), 49, 465, 10.1248/cpb.49.465

Ha, 2002, The effect of rhodiola and acetazolamide on the sleep architecture and blood oxygen saturation in men living at high altitude, Zhonghua Jie He He Hu Xi Za Zhi., 25, 527

Halldorsson, B., 1783. Grasnytjar. Stein A.F., Copenhagen, (reprinted In Akureyri 1983, pp. 241–242).

Heilig, 2004, The NPY system in stress, anxiety and depression, Neuropeptides, 38, 213, 10.1016/j.npep.2004.05.002

Hellum B.H., Tosse A., Hoybakk K., Thomsen M., Rohloff J., Georg Nilsen O., 2009. Potent in vitro inhibition of CYP3A4 and P-glycoprotein by Rhodiola rosea. Planta Med. 29 September 2009 [Epub ahead of print].

Herbert, 2006, Do corticosteroids damage the brain?, J. Neuroendocrinol., 18, 393, 10.1111/j.1365-2826.2006.01429.x

Iaremiı˘, 2002, Hepatoprotective properties of liquid extract of Rhodiola rosea, Eksp. Klin. Farmakol., 65, 57

Jadad, 1996, Assessing the quality of reports of randomized clinical trials: is blinding necessary?, Control Clin. Trials, 17, 1, 10.1016/0197-2456(95)00134-4

Jafari, 2007, Rhodiola: a promising anti-aging Chinese herb, Rejuvenat. Res., 10, 587, 10.1089/rej.2007.0560

Jang, 2003, Salidroside from Rhodiola sachalinensis protects neuronal PC12 cells against cytotoxicity induced by amyloid-beta, Immunopharmacol. Immunotoxicol., 25, 295, 10.1081/IPH-120024498

Kaliko, 1966, Effect of Leuzea and Golden Root extracts on dynamic peculiarities of the highest neural performance, 115

Kelly, 2001, Rhodiola rosea: a possible plant adaptogen, Altern. Med. Rev., 6, 293

Khanum, 2005, Rhodiola rosea: a versatile adaptogen, Comp. Rev. Food Sci. Food Saf., 4, 55, 10.1111/j.1541-4337.2005.tb00073.x

Komar, 1981, The effect of carpatian Rhodiola rosea on human mental activity, Farmatsevtich. Zhurnal., 4, 62

Krasik, 1970, Therapy of asthenic conditions: clinical perspectives of application of Rhodiola rosea extract (golden root), 298

Krasik, 1970, About the adaptogenic and stimulating effect of Rhodiola rosea extract, 215

Kurkin, 1986, Chemical composition and pharmacological properties of Rhodiola rosea L, Khim. Pharm. Z., 20, 1231

Kurkin, 1985, Methods of analysis of identity and quality of Rhodiola rosea roots, Khim. Prir. Soedin., 19, 185

Kurkin, 2003, Neurotropic properties of some phytopreparations containing phenylpropanoids, Rastit. Resursi., 3, 115

Kurkin, 1985, Terpenoids of Rhodiola rosea roots and rhizoama, Khim. Prir. Soedin., 5, 632

Kurkin, 1986, Terpenoids of Rhodiola rosea roots and rhizoama, Khim. Prir. Soedin., 5, 643

Kurkin, 1986, Chemical investigation of some species of the genera Rhodiola L. and Sedum L. and problems of their chemotaxonomy, Rastitel’nye Resursy, 22, 310

Larhammar, 2004, Molecular evolution of NPY receptor subtypes, Neuropeptides, 38, 141, 10.1016/j.npep.2004.06.002

Lazarev, 1958, General and specific in action of pharmacological agents, Farmacol. Toxicol., 21, 81

Lazarev, 1959, State of nonspecific resistance, Patol. Fiziol. Experim. Terapia, 3, 16

Li, 2008, Salidroside stimulated glucose uptake in skeletal muscle cells by activating AMP-activated protein kinase, Eur.J. Pharmacol., 588, 165, 10.1016/j.ejphar.2008.04.036

Linné, 1749

Lishmanov, 1987, Plasma beta-endorphin and stress hormones in stress and adaptation, Biull. Eksp. Biol. Med., 103, 422, 10.1007/BF00842472

Lishmanov, 1996, Effect of Rhodiola rosea on the level of inducible Hsp-70 in miocard in stress, Bull. Exp. Biol. Med., 121, 256, 10.1007/BF02446755

Ma, 2006, Rhodiolosides A-E, monoterpene glycosides from Rhodiola rosea, Chem. Pharm. Bull. (Tokyo), 54, 1229, 10.1248/cpb.54.1229

Ma, 2009, Protective effects of salidroside on oxidative damage in fatigue mice, Zhong Xi Yi Jie He Xue Bao, 7, 237, 10.3736/jcim20090308

Magnusson, 1992

Maı˘meskulova, 1997, The participation of the mu-, delta- and kappa-opioid receptors in the realization of the anti-arrhythmia effect of Rhodiola rosea, Eksp. Klin. Farmakol., 60, 38

Mao, 2007, Simultaneous determination of salidroside and tyrosol in extracts of Rhodiola L. by microwave assisted extraction and high-performance liquid chromatography, J. Pharm. Biomed. Anal., 45, 510, 10.1016/j.jpba.2007.05.031

Mao, 2007, Development of an HPLC method for the determination of salidroside in beagle dog plasma after administration of salidroside injection: application to a pharmacokinetics study, J. Sep. Sci., 30, 3218, 10.1002/jssc.200700273

Marina, T.F., Mikhaleva, L.K., Suslov, N.I., 1994. Comparative effects of para-tyrosol and Rhodiola extract on the central nervous system. In: Proceedings of a joint plenary session of pathophysiologists and pharmacologists of Siberia and the Far East on mechanisms of the development of pathological processes. Kemerovo State University Press, Kemerovo, pp. 66-68.

Mashkovskij, 1977

Maslov, 1997, Do endogenous ligands of peripheral mu- and delta-opiate receptors mediate anti-arrhythmic and cardioprotective effects of Rhodiola rosea extract?, Biull. Eksp. Biol. Med., 124, 151, 10.1007/BF02445082

Mattioli, 2008, Effects of Rhodiola rosea L. extract on behavioural and physiological alterations induced by chronic mild stress in female rats, J. Psychopharmacol., 23, 130, 10.1177/0269881108089872

Mattioli, 2007, Rhodiola rosea L. extract reduces stress- and CRF-induced anorexia in rats, J. Psychopharmacol., 21, 742, 10.1177/0269881106074064

Mikhailova, 1983, Clinical and experimental substantiation of asthenic conditions therapy using Rhodiola rosea extract, 126

Muravijeva, 1978

Müller-Dietz, 1969, Arzneipflanzen in der Sowietunion, Berichte Osteuropa Inst. Freien Univ. Berlin, 44, 91

National Pharmacopoeia Committee, 1996. Pharmacopoeia article PA 42-2163-96, Extractum Rhodiolae fluidum. The Russian Federation Ministry of Health and Medical Industry, Moscow.

National Pharmacopoeia of the USSR, 1990. 11th Ed.—Pharmacopoeia paper 75, Rhizome and roots of Rhodiola rosea. The USSR Ministry of Health, Moscow, Meditsina 2(1), 317–319; update no. 2 dated 19 May 1999.

Olsson, 2009, A randomized double-blind placebo controlled parallell group study of SHR-5 extract of Rhodiola rosea roots as treatment for patients with stress related fatigue, Planta Med., 75, 105, 10.1055/s-0028-1088346

Panossian, 2008, Adaptogens exert a stress protective effect by modulation of expression of molecular chaperons, Planta Med., 74, 1018, 10.1055/s-0028-1084316

Panossian, 2003, Adaptogens: tonic herbs for fatigue and stress, Alt. Comp. Therap., 9, 327, 10.1089/107628003322658610

Panossian, 2007, The adaptogens rhodiola and schizandra modify the response to immobilization stress in rabbits by suppressing the increase of phosphorylated stress-activated protein kinase, nitric oxide and cortisol, Drug Targets Insights, 1, 39

Panossian, 2008, Pharmacokinetic and pharmacodynamic study of interaction of Rhodiola rosea SHR-5 extract with warfarin and theophylline in rats, Phytotherapy Res., 23, 351, 10.1002/ptr.2631

Panossian, A., Hovhannisyan, A., Abrahamyan, H., Wikman, G., 2009b. Pharmacokinetics of active constituents of Rhodiola rosea L. special extract SHR-5. In: Compendium of Bioactive Natural Products Vol. 2: Efficacy, Safety & Clinical Evaluation (Part-1) Stadium Press LLC, USA, pp. 1–23.

Panossian, 2008, Comparative study of Rhodiola preparations on behavioral despair of rats, Phytomedicine, 15, 84, 10.1016/j.phymed.2007.10.003

Panossian, 2005, Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration, Phytother. Res., 19, 819, 10.1002/ptr.1751

Panossian, 2005, Effect of adaptogens on the central nervous system, Arq. Bras. Fitomed. Cient., 2, 108

Panossian, 2009, Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity, Curr. Clin. Pharmacol., 4, 198, 10.2174/157488409789375311

Panossian, A., Wikman, G., 2009b. Evidence-based efficacy of adaptogens in fatigue and molecular mechanisms relared to their stress-protective activity. In: Bonn, K. (Ed.), International Evidence-Based Complementary Medicine Conference, 13–15 Macrh, University of New England, Armidale. p. 10.

Panossian, 2009, Adaptogens exert a stress protective effect by modulation of expression of molecular chaperons, Phytomedicine, 16, 617, 10.1016/j.phymed.2008.12.003

Panossian, 1999, Plant adaptogens: new concepts on their mode of action, Phytomedicine, 6, 1, 10.1016/S0944-7113(99)80023-3

Peng, 2008, HPLC analysis, semi-preparative HPLC preparation and identification of three impurities in salidroside bulk drug, J. Pharm. Biomed. Anal., 49, 828, 10.1016/j.jpba.2008.12.025

Perfumi, 2007, Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice, Phytother. Res., 21, 37, 10.1002/ptr.2013

Petsalo, 2006, Identification of flavonoids of Rhodiola rosea by liquid chromatography–tandem mass spectrometry, J. Chromatogr. A, 1112, 224, 10.1016/j.chroma.2005.11.056

Pharmacopée Française, 1976. 9th Ed.—Premiere Partie Monographs, vol. II-214, La Commission Nationale de Pharmacopee, Paris, pp. 100–101.

Pooja, 2009, Anti-inflammatory activity of Rhodiola rosea—“a second-generation adaptogen”, Phytother. Res., 23, 1099, 10.1002/ptr.2749

Prodius, 1997, Adaptogen ADAPT modulates synthesis of inducible stress protein HSP 70 and increases organism resistance to heat shock, Biull. Eksp. Biol. Med., 123, 629, 10.1007/BF02458073

Qin, 2008, Effects of Rhodiola rosea on level of 5-hydroxytryptamine, cell proliferation and differentiation, and number of neuron in cerebral hippocampus of rats with depression induced by chronic mild stress, Zhongguo Zhong Yao Za Zhi., 33, 2842

Rohloff, 2002, Volatiles from rhizomes of Rhodiola rosea L, Phytochemistry, 59, 655, 10.1016/S0031-9422(02)00004-3

Sajdyk, 2005, Neuropeptide Y receptors as therapeutic targets in anxiety and depression, Drug Dev. Res., 65, 301, 10.1002/ddr.20031

Sandberg, 1993

Saratikov, 1987

Saratikov, 1978, Effect of golden root extract on processes of serotonin synthesis in CNS, J. Biol. Sci., 6, 142

Saratikov, 2004

Saratikov, 1973

Saratikov, 1976, Adaptogenic action of Eleutherococcus and Golden Root preparations

Saratikov, 1968, Rhodiolosid, a new glycoside from Rhodiola rosea and its pharmacological properties, Pharmazie, 23, 392

Saratikov, 1978, Mechanism of action of salidrozide on the metabolism of cerebral catecholamines, Vopr. Med. Khim., 24, 624

Saratikov, 1965, The stimulating effect of Rhodiola rosea on the higher brain structures, Vestnik. Sibirskog Otdeleniya, USSR Acad. Sci., 8, 120

Schriner, 2009, Protection of human cultured cells against oxidative stress by Rhodiola rosea without activation of antioxidant defenses, Free Radic. Biol. Med., 47, 577, 10.1016/j.freeradbiomed.2009.05.025

Schutgens, 2009, The influence of adaptogens on ultraweak biophoton emission: a pilot-experiment, Phytother. Res., 23, 1103, 10.1002/ptr.2753

Shevtsov, 2003, A randomized trial of two different doses of a SHR-5 Rhodiola roseaextract versus placebo and control of capacity for mental work, Phytomedicine, 10, 95, 10.1078/094471103321659780

Siwicki, 2007, The influence of Rhodiola rosea extracts on non-specific and specific cellular immunity in pigs, rats and mice, Centr. Eur. J. Immunol., 32, 84

Skopńska-Rózewska, 2008, The effect of Rhodiola quadrifida extracts oncellular immunity in mice and rats, Pol. J. Vet. Sci., 11, 105

Sokolov, 1990, A comparative study of the stimulant property of certain phenylpropanoids, Khim. Pharm. Z., 24, 66

Sokolov, 1985, Study of neurotropic activity of new substances isolated from Rhodiola rosea, Khim. Pharm. Z., 19, 1367

Song, 2003, Hepatoprotective phenolic constituents of Rhodiola sachalinensis on tacrine-induced cytotoxicity in Hep G2 cells, Phytother. Res., 17, 563, 10.1002/ptr.1166

Sparschuch, H., 1775. Pharmacopoae Svecia, Holmia, p. 39.

Spasov, 2000, A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen, Phytomedicine, 7, 85, 10.1016/S0944-7113(00)80078-1

Strandberg, K., Aly, K.-O., 1997.Läkemedelsboken 97/98, Naturläkemedel, Apoteksbolaget AB, pp. 870–879.

Tasan, 2009, Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice, Neuroscience, 158, 1717, 10.1016/j.neuroscience.2008.11.048

Tolonen, 2003, Phenylpropanoid glycosides from Rhodiola rosea, Chem. Pharm. Bull. (Tokyo), 51, 467, 10.1248/cpb.51.467

Tolonen, 2004, Fast screening method for the analysis of total flavonoid content in plants and foodstuffs by high-performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry with polarity switching, Rapid Commun. Mass Spectrom., 18, 3113, 10.1002/rcm.1736

Turova, 1984

Wagner, 1994, Plant adaptogens, Phytomedicine, 1, 63, 10.1016/S0944-7113(11)80025-5

Walker, 2006, Does Rhodiola rosea possess ergogenic properties?, Int. J. Sport Nutr. Exerc. Metab., 16, 305, 10.1123/ijsnem.16.3.305

van Diermen, 2009, Monoamine oxidase inhibition by Rhodiola rosea L. roots, J. Ethnopharmacol., 122, 397, 10.1016/j.jep.2009.01.007

Wang, 2009, The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3, Phytomedicine, 16, 146, 10.1016/j.phymed.2008.07.013

Wang, 2008, Effects of salidroside on carbohydrate metabolism and differentiation of 3T3-L1 adipocytes, Zhong Xi Yi Jie He Xue Bao., 2, 193, 10.3736/jcim20040312

Wiedenfeld, 2007, Phytochemical and analytical studies of extracts from Rhodiola rosea and Rhodiola quadrifida, Pharmazie, 62, 308

Wiegant, 2009, Plant adaptogens increase lifespan and stress resistance in C. elegans, Biogerontology., 10, 27, 10.1007/s10522-008-9151-9

Wiegant, 2008, Plant adaptogens activate cellular adaptive mechanisms by causing mild damage, vol. 5, 319

Virey, J.-J., 1811. Traite de pharmacie théorique et pratique, p. 92.

Wu, S., Zu, Y., Wu, M., 2003. High yield production of salidroside in the suspension culture of Rhodiola sachalinensis. J Biotechnol. 106, 33–43

Wu, 2008, Protective effects of salidroside against acetaminophen-induced toxicity in mice, Biol. Pharm. Bull., 31, 1523, 10.1248/bpb.31.1523

Wu, 2004, GC–MS analysis of supercritical carbon dioxide extraction products from Rhodiola tibetica, Zhongguo Zhong Yao Za Zhi., 29, 239

Xu, 2003, Preventive and treatment effect of composite Rhodiolae on acute lung injury in patients with severe pulmonary hypertension during extracorporeal circulation, Zhongguo Zhong Xi Yi Jie He Za Zhi., 23, 648

Ye, 1993, Effect of salidroside on cultured myocardial cells anoxia/reoxygenation injuries, Zhongguo Yao Li Xue Bao., 14, 424

Yousef, 2006, Comparative phytochemical characterization of three Rhodiola species, Phytochemistry, 67, 2380, 10.1016/j.phytochem.2006.07.026

Yu, 2008, Neuroprotective effects of salidroside in the PC12 cell model exposed to hypoglycemia and serum limitation, Cell. Mol. Neurobiol., 28, 1067, 10.1007/s10571-008-9284-z

Zapesochnaya, 1983, Flavonoids of Rhodiola rosea roots II, Khim. Prir. Soedin., 1983, 23

Zapesochnaya, 1982, Glycosides of cinnamic alcohol from Rhodiola rosea roots and rhizoma, Khim. Prir. Soedin., 18, 723

Zapesochnaya, 1995, Phenylpropanoids—promising biologically active compounds of medicinal plants, Khim. Pharm. Z., 29, 47

Zdanowska, 2009, The effect of Rhodiola rosea extracts on the bacterial infection in mice, Centr. Eur. J. Immunol., 34, 35

Zhang, 2009, Salidroside protects cardiomyocyte against hypoxia-induced death: a HIF-1alpha-activated and VEGF-mediated pathway, Eur. J. Pharmacol., 607, 6, 10.1016/j.ejphar.2009.01.046

Zhang, 2007, Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells, Eur. J. Pharmacol., 564, 18, 10.1016/j.ejphar.2007.01.089

Zhang, 1999, Early use of Chinese drug rhodiola compound for patients with post-trauma and inflammation in prevention of ALI/ARDS, Zhonghua Wai Ke Za Zhi., 37, 238

Zhang, 2004, Protective effects of salidroside on injury induced by hypoxia/hypoglycemia in cultured neurons, Zhongguo Zhong Yao Za Zhi., 29, 459

Zhang, 2006, Effects of salidroside on bone marrow matrix metalloproteinases of bone marrow depressed anemic mice, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi., 23, 1314

Zhang, 2005, Effect of salidroside on bone marrow cell cycle and expression of apoptosis-related proteins in bone marrow cells of bone marrow depressed anemia mice, Sichuan Da Xue Xue Bao Yi Xue Ban., 36, 820

Zhang, 2005, Study on effects of salidroside on lipid peroxidation on oxidative stress in rat hepatic stellate cells, Zhong Yao Cai., 28, 794

Zotova, M.I., 1965. The effect of Rhodiola rosea extract on mental working activity in man. In: Collection of Reports at Third Scientific Conference Of Physiologists. Tomsk, Biochemists and Pharmacologists of Western Siberia., pp. 298–299.

Zou, 2009, Effects of salidroside-pretreatment on neuroethology of rats after global cerebral ischemia-reperfusion, Zhong Xi Yi Jie He Xue Bao., 7, 130, 10.3736/jcim20090207